Related references
Note: Only part of the references are listed.Mast cells, brain inflammation and autism
Theoharis C. Theoharides et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
Gloria B. Choi et al.
SCIENCE (2016)
From molecules to neural morphology: understanding neuroinflammation in autism spectrum condition
Adam M. H. Young et al.
MOLECULAR AUTISM (2016)
Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders
T. C. Theoharides et al.
TRANSLATIONAL PSYCHIATRY (2016)
Dynamic light scattering analysis of SNARE-driven membrane fusion and the effects of SNARE-binding flavonoids
Yoosoo Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The blood-brain barrier endothelium: a target for pro-inflammatory cytokines
Keith D. Rochfort et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Autism spectrum disorders: from genes to neurobiology
A. Jeremy Willsey et al.
CURRENT OPINION IN NEUROBIOLOGY (2015)
The crucial role of mast cells in blood-brain barrier alterations
Domenico Ribatti
EXPERIMENTAL CELL RESEARCH (2015)
The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells
Zuyi Weng et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism
Kimberly M. Huber et al.
JOURNAL OF NEUROSCIENCE (2015)
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Myka L. Estes et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Mast Cells, Mastocytosis, and Related Disorders
Theoharis C. Theoharides et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Intersection of mTOR and STAT signaling in immunity
Diana Saleiro et al.
TRENDS IN IMMUNOLOGY (2015)
Microglia Plasticity During Health one Disease: An Immunological Perspective
Anat Shemer et al.
TRENDS IN IMMUNOLOGY (2015)
Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6
I. Tsilioni et al.
TRANSLATIONAL PSYCHIATRY (2015)
Roles of mTOR Signaling in Brain Development
Da Yong Lee
EXPERIMENTAL NEUROBIOLOGY (2015)
Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis
A. Masi et al.
MOLECULAR PSYCHIATRY (2015)
From Kanner to DSM-5: Autism as an Evolving Diagnostic Concept
Fred R. Volkmar et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 10 (2014)
The Subpopulation of Microglia Sensitive to Neurotransmitters/Neurohormones Is Modulated by Stimulation with LPS, Interferon- γ, and IL-4
Maria Pannell et al.
GLIA (2014)
Mast cells, glia and neuroinflammation: partners in crime?
Stephen D. Skaper et al.
IMMUNOLOGY (2014)
Histamine Induces Upregulated Expression of Histamine Receptors and Increases Release of Inflammatory Mediators from Microglia
Hongquan Dong et al.
MOLECULAR NEUROBIOLOGY (2014)
Stereological Study of Amygdala Glial Populations in Adolescents and Adults with Autism Spectrum Disorder
John T. Morgan et al.
PLOS ONE (2014)
Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism
Simone Gupta et al.
NATURE COMMUNICATIONS (2014)
Selective Activation of mTORC1 Signaling Recapitulates Microcephaly, Tuberous Sclerosis, and Neurodegenerative Diseases
Hidetoshi Kassai et al.
CELL REPORTS (2014)
Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism
I. Tsilioni et al.
TRANSLATIONAL PSYCHIATRY (2014)
Polyphenols differentially inhibit degranulation of distinct subsets of vesicles in mast cells by specific interaction with granule-type-dependent SNARE complexes
Yoosoo Yang et al.
BIOCHEMICAL JOURNAL (2013)
Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development
Paula A. Garay et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
An Open-Label Pilot Study of a Formulation Containing the Anti-Inflammatory Flavonoid Luteolin and Its Effects on Behavior in Children With Autism Spectrum Disorders
Anilia Taliou et al.
CLINICAL THERAPEUTICS (2013)
Focal brain inflammation and autism
Theoharis C. Theoharides et al.
JOURNAL OF NEUROINFLAMMATION (2013)
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Mauro Costa-Mattioli et al.
NATURE NEUROSCIENCE (2013)
Drug discovery for autism spectrum disorder: challenges and opportunities
Anirvan Ghosh et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Genomic responses in mouse models poorly mimic human inflammatory diseases
Junhee Seok et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Reversing autism by targeting downstream mTOR signaling
Hansen Wang et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Microglial Activation in Young Adults With Autism Spectrum Disorder
Katsuaki Suzuki et al.
JAMA PSYCHIATRY (2013)
Inflammation during fetal and neonatal life: Implications for neurologic and neuropsychiatric disease in children and adults
Henrik Hagberg et al.
ANNALS OF NEUROLOGY (2012)
Mast Cell Tryptase Induces Microglia Activation via Protease-activated Receptor 2 Signaling
Shu Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Microglia and mast cells: two tracks on the road to neuroinflammation
Stephen D. Skaper et al.
FASEB JOURNAL (2012)
Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models
Yukio Takeshita et al.
IMMUNOLOGICAL REVIEWS (2012)
A CASE SERIES OF A LUTEOLIN FORMULATION (NEUROPROTEK®) IN CHILDREN WITH AUTISM SPECTRUM DISORDERS
T. C. Theoharides et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)
Evidence of microglial activation in autism and its possible role in brain underconnectivity
Juan I. Rodriguez et al.
Neuron Glia Biology (2012)
Modeling an autism risk factor in mice leads to permanent immune dysregulation
Elaine Y. Hsiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome
Paul Ashwood et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy
Seth A. Wander et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia
Tsung-Kuei Kao et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Rosa C. Paolicelli et al.
SCIENCE (2011)
Microglial Activation and Increased Microglial Density Observed in the Dorsolateral Prefrontal Cortex in Autism
John T. Morgan et al.
BIOLOGICAL PSYCHIATRY (2010)
Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype
Konstantin Dirscherl et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Neurotensin is increased in serum of young children with autistic disorder
Asimenia Angelidou et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation
Cinzia Dello Russo et al.
BIOCHEMICAL PHARMACOLOGY (2009)
The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly
Elizabeth A. Varga et al.
GENETICS IN MEDICINE (2009)
Flavonoids, a prenatal prophylaxis via targeting JAK2/STAT3 signaling to oppose IL-6/MIA associated autism
Ellisa Parker-Athill et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Elevated immune response in the brain of autistic patients
Xiaohong Li et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Han C. Dan et al.
GENES & DEVELOPMENT (2008)
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Thomas Weichhart et al.
IMMUNITY (2008)
Autism, gut-blood-brain barrier, and mast cells
Theoharis C. Theoharides et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Activation and function of the mTORC1 pathway in mast cells
Mi-Sun Kim et al.
JOURNAL OF IMMUNOLOGY (2008)
Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1
Saebyeol Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Corticotropin-releasing hormone (CRH) regulates macromolecular permeability via mast cells in normal human colonic biopsies in vitro
C. Wallon et al.
GUT (2008)
Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption
Thomas Walle
MOLECULAR PHARMACEUTICS (2007)
Anti-inflammatory mechanisms of isoflavone metabolites in lipopolysaccharide-stimulated microglial cells
Jin-Sun Park et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process
Jill Donelan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Pten regulates neuronal arborization and social interaction in mice
Chang-Hyuk Kwon et al.
NEURON (2006)
Cerebrospinal fluid and serum markers of inflammation in autism
AW Zimmerman et al.
PEDIATRIC NEUROLOGY (2005)
Neurotensin and the neurotensin receptor-3 in microglial cells
S Martin et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations
MG Butler et al.
JOURNAL OF MEDICAL GENETICS (2005)
Neuroglial activation and neuroinflammation in the brain of patients with autism
DL Vargas et al.
ANNALS OF NEUROLOGY (2005)
Neurotensin receptor-3/sortilin mediates neurotensin-induced cytokine/chemokine expression in a murine microglial cell line
E Dicou et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress
P Esposito et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line
V Navarro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Neuropathology of infantile autism
TL Kemper et al.
MOLECULAR PSYCHIATRY (2002)
Pharmacological properties of the mouse neurotensin receptor 3. Maintenance of cell surface receptor during internalization of neurotensin
V Navarro et al.
FEBS LETTERS (2001)
Share Paper
